Woffa2 not sure what you mean. The Lim family are bound by the restrictions placed upon them as company directors. They can increase their holdings by exercising some of the swag of options they hold at some point but can't simply put money in the kitty if that is what you are inferring.
As a public company all of their dealings have to be at arms length and all we know re the financing of the deal right now is that they have about $100M cash, plan to raise an extra $130 with a rights (more shares) issue but we have no idea how the remainder will be secured other than a previous statement saying that debt will be part of the mix.
Also they do have the option to issue scrip (raise more shares) to the vendor which was part of the original announcement. This might still be on the table but nobody really knows until we get the detail, hopefully Friday but probably next week. If it starts to drag on substantially we will know that they are possibly having a problem with the funding.
DNA Price at posting:
54.5¢ Sentiment: Buy Disclosure: Held
